Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Brogden

Showing results (21-30 of 251) with videos related to

Pageof 26
Sort By:
Drugs|May 1, 1991
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disordersD Murdoch, R N Brogden
Drugs & Aging|May 1, 1994
Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failureA Fitton, R N Brogden
Drugs|December 1, 1988
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain statesA Ward, R N Brogden
Drugs|November 14, 1997
Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectorisR N Brogden, A Markham
Drugs|May 1, 1985
Diltiazem. A review of its pharmacological properties and therapeutic efficacyM Chaffman, R N Brogden
Drugs|May 1, 1993
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D McTavish
Drugs|June 1, 1988
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administrationR N Brogden, A Ward
Drugs|June 1, 1995
Cefixime. A review of its therapeutic efficacy in lower respiratory tract infectionsA Markham, R N Brogden
Drugs|June 1, 1994
Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, A Fitton
Drugs|May 1, 1991
Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular diseaseF Deget, R N Brogden
Pageof 26

Showing results (21-30 of 251) with videos related to

Sort By:
Pageof 26
Drugs|May 1, 1991
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disordersD Murdoch, R N Brogden
Drugs & Aging|May 1, 1994
Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failureA Fitton, R N Brogden
Drugs|December 1, 1988
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain statesA Ward, R N Brogden
Drugs|November 14, 1997
Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectorisR N Brogden, A Markham
Drugs|May 1, 1985
Diltiazem. A review of its pharmacological properties and therapeutic efficacyM Chaffman, R N Brogden
Drugs|May 1, 1993
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D McTavish
Drugs|June 1, 1988
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administrationR N Brogden, A Ward
Drugs|June 1, 1995
Cefixime. A review of its therapeutic efficacy in lower respiratory tract infectionsA Markham, R N Brogden
Drugs|June 1, 1994
Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, A Fitton
Drugs|May 1, 1991
Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular diseaseF Deget, R N Brogden
Pageof 26